A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia. (2016)

First Author: Tzelepis K
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.celrep.2016.09.079

PubMed Identifier: 27760321

Publication URI: http://europepmc.org/abstract/MED/27760321

Type: Journal Article/Review

Volume: 17

Parent Publication: Cell reports

Issue: 4